Intravascular Catheters Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal intravascular catheters market size was valued at USD 4.1 billin in 2018 and is anticipated t grw at a lucrative rate ver the frecast perid. The glbal Intravascular Catheters Market size is expected t reach USD 8.8 billin by 2025, accrding t a new reprt by Grand View Research, Inc., registering an 11.8% CAGR during the frecast perid. Increasing number f surgical prcedures requiring catheters, grwing awareness abut hspital-acquired infectins, and increasing cverage f healthcare insurance are sme f the factrs cntributing t the demand fr intravascular catheters frm 2019 t 2025. The market is als expected t be driven by increasing number f patients underging cardivascular as well as urlgical prcedures and rising incidents f trauma injuries. Shrt Peripheral Intravascular Catheters (PIVC) dminated the market with a revenue f USD 2.8 billin in 2018, n accunt f lwer infectin risk assciated with these prducts. In additin, shrt PIVCs are preferred ver ther catheters due t their quick discharge and shrt dwelling time. This prduct segment is expected t witness lucrative CAGR between 2018 t 2025 as a cnsequence f increasing cncerns ver catheterassciated bldstream infectins leading t catheter clnizatin. Hspitals dminated the market n the basis f end use in 2018, with a revenue f USD 2.5 billin. The trend is likely t cntinue ver the frecast perid wing t increase in number f surgical prcedures requiring catheters, grwing health insurance cverage, and rising hspital admissins. Ambulatry Surgical Centers
(ASC) are anticipated t witness the fastest grwth, with a CAGR f 13.5% thrugh 2025. Surgical prcedures are cheaper in ASCs as cmpared t hspitals. As a result, the market is expected t witness a rise in adptin f surgical prcedures in ASCs, which in turn is anticipated t drive demand fr intravascular catheters ver the frecast perid. Asia Pacific dminated the intravascular catheters market with a revenue f USD 1.2 billin in 2018, wing t high patient base, increasing investments in healthcare infrastructure, grwing insurance cverage, and availability f reimbursements. This regin is anticipated t witness lucrative grwth due t its high ptential in vercming unmet medical needs amng patients suffering frm cardivascular and urlgical diseases as well as trauma injuries. China dminated the APAC market with a 23.3% revenue share in 2018 wing t high unmet medical needs, grwing awareness abut hspital-acquired infectins, and increase in healthcare accessibility. Thus, a high ppulatin base with unmet medical needs is expected t drive demand fr intravascular catheters between 2018 t 2025. T request a sample cpy r view summary f this reprt, click the link belw: https://www.grandviewresearch.cm/industry-analysis/intravascular-catheters-market Further key findings frm the reprt suggest: Asia Pacific dminated the market in 2018 with a revenue f USD 1.2 billin, wing t factrs such as large patient base, grwing awareness regarding hspital-acquired infectins, increase in healthcare access, and expanding healthcare cverage U.S. is the largest cuntry with an incremental pprtunity f USD 542.0 millin frm 2019 t 2025 The hspitals segment dminated the market by end use in 2018 wing t grwing number f surgical prcedures requiring intravascular catheters and increasing hspital admissins Sme f the key players in this market are Bstn Scientific Crpratin; C.R. Bard, Inc.; Jhnsn & Jhnsn Services, Inc.; Abbtt; Clplast Ltd; Smith Medical; Edwards Lifesciences Crpratin; Medtrnic; McKessn Medical Surgical Inc.; and TERUMO CORPORATION. Grand View Research has segmented the glbal intravascular catheters market n the basis f prduct, applicatin, end use, and regin:
Intravascular Catheters Prduct Outlk (Revenue, USD Millin, 2014-2025) Shrt PIVC Integrated/Clsed PIVC Intravascular Catheters Applicatin Outlk (Revenue, USD Millin, 2014-2025) Onclgy Gastrenterlgy Renal Disease Infectius Diseases Others Intravascular Catheters End-use Outlk (Revenue, USD Millin, 2014-2025) Hspitals Clinics ASC Hmecare Others Intravascular Catheters Reginal Outlk (Revenue, USD Millin, 2014-2025) Nrth America U.S. Canada Eurpe Germany U.K.
Spain France Italy Russia Asia Pacific Japan China India Suth Krea Singapre Australia Latin America Mexic Brazil Argentina MEA Suth Africa Saudi Arabia UAE
Table f Cntent f Intravascular Catheters Market Chapter 1 Methdlgy and Scpe 1.1 Market Segmentatin & Scpe 1.2 Market Definitin 1.3 Infrmatin Prcurement 1.3.1 Purchased Database 1.3.2 GVR s Internal Database 1.3.3 Secndary Surces & Third Party perspectives 1.3.4 Primary Research 1.4 Infrmatin Analysis 1.4.1 Data Analysis Mdels 1.5 Market Frmulatin & Data Visualizatin 1.6 Data Validatin & Publishing Chapter 2 Executive Summary 2.1 Intravascular Catheters Market Outlk, By Revenue (USD Millin) 2.2 Intravascular Catheters Market Segment Outlk, By Revenue (USD Millin) 2.3 Cmpetititve Insights Chapter 3 Intravascular Catheters Market Variables, Trends and Scpe 3.1 Market Lineage Outlk 3.1.1 Market Outlk 3.2 Penetratin & Grwth Prspect Mapping 3.3 Prduct Pipeline Analysis, by Stage 3.4 Industry Value Chain Analysis 3.4.1 User Perspective Analysis 3.4.1.1 Cnsumer Behaviur Analysis 3.4.1.2 Market Influencer Analysis 3.4.2 Intravascular Catheters Cst Structure Analysis 3.4.3 List f Key End-users, By Regin/By Prduct/By Cuntry 3.5 Technlgy Overview 3.5.1 Technlgy Timeline
3.6 Regulatry Framewrk 3.6.1 Reimbursement Framewrk 3.6.2 Standards & Cmpliances 3.7 Market Dynamics 3.7.1 Market Driver Analysis 3.7.1.1 Increasing Prevalance f Cardivascular Diseases 3.7.1.2 Increasing Prevalence f Diabetes 3.7.1.3 Increasing Prevalence f End Stage Renal Disease (ESRD) 3.7.2 Market Restraint Analysis 3.7.2.1 Lw Penetratin f Reimbursement and High Percentage f Out-f-pcket Expenditure in Emerging Markets 3.7.3 Industry Challenges 3.8 Intravascular Catheters Market Analysis Tls 3.8.1 Industry Analysis - Prter's 3.8.1.1 Supplier Pwer 3.8.1.2 Buyer Pwer 3.8.1.3 Substitutin Threat 3.8.1.4 New Entrants Threat 3.8.1.5 Cmpetitive Rivalry 3.8.2 PESTEL Analysis 3.8.2.1 Plitical Landscape 3.8.2.2 Ecnmic Landscape 3.8.2.3 Scial Landscape 3.8.2.4 Technlgy Landscape 3.8.3 Majr Deals and Strategic Alliances Analysis 3.8.4 Market Entry Strategies 3.8.5 Case Studies Chapter 4 Intravascular Catheters Market - Cmpetitive Analysis 4.1 Recent Develpments & Impact Analysis, by Key Market Participants 4.2 Cmpany/Cmpetitin Categrizatin (Key innvatrs, Market leaders, Emerging Players) 4.3 Public Cmpanies
4.3.1 Cmpany Market Psitin Analysis 4.3.2 Cmpany Market Share/Regin, by Regin 4.4 Private Cmpanies 4.4.1 List f Key Emerging Cmpanies/Technlgy Disruptrs/Innvatrs 4.4.2 Reginal Netwrk Map 4.4.3 Cmpany Market Psitin Analysis (Gegraphic Presence, Prduct Prtfli, Key Alliance, Industry Experience) 4.5.4 Supplier Ranking Chapter 5 Intravascular Catheters Market: Prduct Estimates & Trend Analysis 5.1 Definitins & Scpe 5.2 Intravascular Catheters Market Share by Prduct, 2018 & 2025 5.3 Segment Dashbard 5.4 Shrt PIVC catheters 5.4.1 Shrt PIVC catheters market estimates and frecasts, 2014-2025 (USD Millin) 5.4.2 Shrt PIVC catheters market estimates and frecasts, by applicatin, 2014-2025 (USD Millin) 5.5 Integrated/Clsed PIVC catheters 5.5.1 Integrated/Clsed PIVC catheters market estimates and frecasts, 2014-2025 (USD Millin) 5.5.2 Integrated/Clsed PIVC catheters market estimates and frecasts, by applicatin, 2014-2025 (USD Millin) Chapter 6 Intravascular Catheters Market: Applicatin Estimates & Trend Analysis 6.1 Definitins & Scpe 6.2 Intravascular Catheters Market Share by Prduct, 2018 & 2025 6.3 Segment Dashbard 6.4 Onclgy 6.4.1 Onclgy market estimates and frecasts, 2014-2025 (USD Millin) 6.5 Gastrenterlgy 6.5.1 Gastrenterlgy market estimates and frecasts, 2014-2025 (USD Millin) 6.6 Renal Disease 6.6.1 Renal Disease Market Estimates And Frecasts, 2014-2025 (USD Millin) 6.7 Infectius Diseases 6.7.1 Infectius Diseases Market Estimates And Frecasts, 2014-2025 (USD Millin)
6.8 Other Diseases 6.8.1 Other Diseases Market Estimates And Frecasts, 2014-2025 (USD Millin) Chapter 7 Intravascular Catheters Market: End Use Estimates & Trend Analysis 7.1 Definitins & Scpe 7.2 Intravascular Catheters Market Share by Raw Materials, 2018 & 2025 7.3 Segment Dashbard 7.4 Hspitals 7.4.1 Hspitals Market Estimates And Frecasts, 2014-2025 (USD Millin) 7.5 Clinics 7.5.1 Clinics Market Estimates And Frecasts, 2014-2025 (USD Millin) 7.6 ASC 7.6.1 ASC Market Estimates And Frecasts, 2014-2025 (USD Millin) 7.7 Hmecare 7.7.1 Hmecare Market Estimates And Frecasts, 2014-2025 (USD Millin) 7.8 Others 7.8.1 Others Market Estimates And Frecasts, 2014-2025 (USD Millin) Chapter 8 Intravascular Catheters Market: Reginal Estimates & Trend Analysis, by Prduct 8.1 Reginal Market Snapsht 8.2 Reginal Market Share and Leading Players, 2018 8.2.1 Nrth America 8.2.2 Eurpe 8.2.3 Asia Pacific 8.2.4 Latin America 8.2.5 Middle East & Africa 8.3 SWOT Analysis, by Factr (Plitical & Legal, Ecnmic and Technlgical) 8.3.1 Nrth America 8.3.2 Eurpe 8.3.3 Asia Pacifc 8.3.4 Latin America 8.4.5 Middle East & Africa 8.4 Intravascular Catheters Market Size, & Frecasts, and Trend Analysis, 2018 t 2025:
8.4.1 Nrth America 8.4.1.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.1.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.1.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.1.4 U.S. 8.4.1.4.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.1.4.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.1.4.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.1.5 Canada 8.4.1.5.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.1.5.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.1.5.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.2 Eurpe 8.4.2.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.2.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.2.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.2.4 U.K. 8.4.2.4.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.2.4.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.2.4.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.2.5 Germany 8.4.2.5.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.2.5.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.2.5.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.2.6 Spain 8.4.2.6.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.2.6.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.2.6.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.2.7 France 8.4.2.7.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.2.7.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin)
8.4.2.7.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.2.8 Italy 8.4.2.8.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.2.8.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.2.8.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.2.9 Russia 8.4.2.9.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.2.9.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.2.9.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.3 Asia Pacific 8.4.3.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.3.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.3.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.3.4 China 8.4.3.4.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.3.4.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.3.4.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.3.5 Japan 8.4.3.5.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.3.5.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.3.5.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.3.6 India 8.4.3.6.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.3.6.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.3.6.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.3.7 Suth Krea 8.4.3.7.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.3.7.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.3.7.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.3.8 Singapre 8.4.3.8.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin)
8.4.3.8.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.3.8.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.3.9 Australia 8.4.3.9.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.3.9.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.3.9.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.4 Latin America 8.4.4.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.4.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.4.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.4.4 Brazil 8.4.4.4.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.4.4.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.4.4.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.4.5 Mexic 8.4.4.5.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.4.5.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.4.5.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.4.6 Argentina 8.4.4.6.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.4.6.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.4.6.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.5 Middle East & Africa (MEA) 8.4.5.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.5.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.5.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.5.4 Suth Africa 8.4.5.4.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.5.4.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.5.4.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.5.5 Saudi Arabia
8.4.5.5.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.5.5.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.5.5.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) 8.4.5.6 UAE 8.4.5.6.1 Market estimates and frecasts, by prduct 2014-2025 (USD Millin) 8.4.5.6.2 Market estimates and frecasts, by end use 2014-2025 (USD Millin) 8.4.5.6.3 Market estimates and frecasts, by applicatin 2014-2025 (USD Millin) Chapter 9 Cmpetitive Landscape 9.1 Cmpany Prfiles 9.1.1 C.R. Bard, Inc. 9.1.1.1 Cmpany Overview 9.1.1.2 Financial Perfrmance 9.1.1.3 Prduct Benchmarking 9.1.1.4 Strategic Initiatives 9.1.2 Clplast 9.1.2.1 Cmpany Overview 9.1.2.2 Financial Perfrmance 9.1.2.3 Prduct Benchmarking 9.1.2.4 Strategic Initiatives 9.1.3 Getinge AB 9.1.3.1 Cmpany Overview 9.1.3.2 Financial Perfrmance 9.1.3.3 Prduct Benchmarking 9.1.3.4 Strategic Initiatives 9.1.4 Bstn Scientific Crpratin 9.1.4.1 Cmpany Overview 9.1.4.2 Financial Perfrmance 9.1.4.3 Prduct Benchmarking 9.1.4.4 Strategic Initiatives 9.1.5 Jhnsn & Jhnsn 9.1.5.1 Cmpany Overview
9.1.5.2 Financial Perfrmance 9.1.5.3 Prduct Benchmarking 9.1.5.4 Strategic Initiatives 9.1.6 Smiths Medical 9.1.6.1 Cmpany Overview 9.1.6.2 Financial Perfrmance 9.1.6.3 Prduct Benchmarking 9.1.6.4 Strategic Initiatives 9.1.7 Edwards Life Sciences Crpratin 9.1.7.1 Cmpany Overview 9.1.7.2 Financial Perfrmance 9.1.7.3 Prduct Benchmarking 9.1.7.4 Strategic Initiatives 9.1.8 Medtrnic, Inc. 9.1.8.1 Cmpany Overview 9.1.8.2 Financial Perfrmance 9.1.8.3 Prduct Benchmarking 9.1.8.4 Strategic Initiatives 9.1.9 Ck Medical 9.1.9.1 Cmpany Overview 9.1.9.2 Financial Perfrmance 9.1.9.3 Prduct Benchmarking 9.1.9.4 Strategic Initiatives 9.1.10 McKessn Medical Surgical Inc. 9.1.10.1 Cmpany Overview 9.1.10.2 Financial Perfrmance 9.1.10.3 Prduct Benchmarking 9.1.10.4 Strategic Initiatives 9.1.11 TERUMO CORPORATION 9.1.11.1 Cmpany Overview 9.1.11.2 Financial Perfrmance
9.1.11.3 Prduct Benchmarking 9.1.11.4 Strategic Initiatives 9.2 List f Other Cmpanies Abut Us: Grand View Research, Inc. is a U.S. based market research and cnsulting cmpany, registered in the State f Califrnia and headquartered in San Francisc. The cmpany prvides syndicated research reprts, custmized research reprts, and cnsulting services. T help clients make infrmed business decisins, the cmpany ffers market intelligence studies ensuring relevant and fact-based research acrss a range f industries including technlgy, chemicals, materials, healthcare and energy. Cntact: Sherry James Crprate Sales Specialist, USA Grand View Research, Inc
Phne: 1-415- 349-0058 Tll Free: 1-888- 202-9519 Email: sales@grandviewresearch.cm Fr Mre Infrmatin: https://www.grandviewresearch.cm Blg: https://healthcarefrecastreprt.blgspt.cm/